Intervention: Plitidepsin

THALASSA

Spain
|
2025-2026
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Plitidepsin
  • Antineoplastic agent

Aguareles

Spain
|
2022-2023
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Fragile population
  • Immunocompromised host
  • Hospital
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Antivirals
  • Plitidepsin

E-APLICOV-PC

Spain
|
2022-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Antivirals
  • Plitidepsin